A Study of Belimumab in Idiopathic Membranous Glomerulonephropathy
NCT01610492
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
14
Enrollment
INDUSTRY
Sponsor class
Conditions
Glomerulonephritis, Membranous
Interventions
DRUG:
belimumab
Sponsor
GlaxoSmithKline